Patents by Inventor Linda Hammill

Linda Hammill has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vesicular monoamine transporter-2 ligands and their use in the treatment of psychostimulant abuse
    Patent number: 11999676
    Abstract: The present invention relates to methods of treatment of a disease or pathology of the central nervous system, an eating disorder, or substance use disorder, drug dependence/abuse and withdrawal therefrom comprising administering at least one N-phenylalkyl amphetamine derivative and pharmaceutical compositions comprising at least one N-phenylalkyl amphetamine derivative to an individual in need thereof.
    Type: Grant
    Filed: April 14, 2020
    Date of Patent: June 4, 2024
    Assignee: University of Kentucky Research Foundation
    Inventors: Linda P. Dwoskin, David Watt, Jon Thorson, Mark Leggas, Kip Guy, Jared Hammill, Stefan Kwiatkowski, Derong Ding, Guangrong Zheng, Peter Anthony Crooks, Na-Ra Lee
  • Compositions for expression of proteins in host cells using a preprocollagen signal sequence
    Patent number: 5712114
    Abstract: Hybrid genes comprising a nucleotide sequence encoding a preprocollagen signal sequence operatively linked to a nucleotide sequence encoding a heterologous protein are disclosed. The hybrid genes are useful for secretion of heterologous proteins from host cells. In a preferred embodiment, the signal sequence of the human preprocollagen .alpha.1(I) protein is linked to a heterologous protein of interest to allow for secretion of the protein from Hansenula polymorpha cells.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: January 27, 1998
    Assignee: BASF Aktiengesellschaft
    Inventors: John A. Mankovich, Linda Hammill, Catherine R. Ferenz